Solid Biosciences (SLDB) Price to Sales (2022 - 2023)
Solid Biosciences' (SLDB) Price to Sales stood at 17.03 in Q2 2023, up 50.9% from 11.28 a year earlier.
Powered by 
Analysis
Solid Biosciences (SLDB) Price to Sales (2022 - 2023) Analysis & Trends
For FY2022, Solid Biosciences' Price to Sales came in at 5.66, down 60.9% from FY2021.
- Across earlier years, Price to Sales came in at 14.46 in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Solid Biosciences | 1.08 Bn | -212.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 17.03 |
| Dec 31, 2022 | 7.44 |
| Sep 30, 2022 | 8.60 |
| Jun 30, 2022 | 11.33 |
API Access
Solid Biosciences Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=SLDB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "SLDB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=SLDB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();